MGMelanie Gerard

Melanie Gerard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Melanie Gerard has a total of 118 co-authors. Here are the top co-authors by number of shared publications:

  • Veerle Baekelandt

    Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Leuven, Belgium

    12 shared publications
  • Zeger Debyser

    Laboratory for Molecular Virology and Gene therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium

    8 shared publications
  • Angélique Deleersnijder

    KU Leuven, Laboratory for Neurobiology and Gene Therapy, Kapucijnenvoer 33, Leuven B-3000, Flanders, Belgium

    7 shared publications
  • Anne-Marie Lambeir

    Laboratory of Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium

    5 shared publications
  • Yves Engelborghs

    Laboratory of Biomolecular Dynamics, Katholieke Universiteit Leuven, Celestijnenlaan 200G, B-3001 Leuven, Belgium

    5 shared publications
  • Frauke Christ

    Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Flanders, Belgium

    4 shared publications

Latest Publications

  • Open Access

    Direct versus indirect 3D printing of photo-crosslinkable hybrid hydrogels based on gelatin and poly(aspartic acid) derivatives

    by Lauren De Grave, Celeste Di Meo, Melanie Gérard, Annalisa La Gatta, Lieven Thorrez, Katrien V. Bernaerts, Chiara Schiraldi, Sandra Van Vlierberghe

    Direct versus indirect 3D printing of photo-crosslinkable hybrid hydrogels based on gelatin and poly(aspartic acid) derivatives, Lauren De Grave, Celeste Di Meo, Melanie Gerard, Annalisa La Gatta, Lieven Thorrez, Katrien V. Bernaerts, Chiara Schiraldi, Sandra Van Vlierberghe Direct versus indirect 3D printing of photo-crosslinkable hybrid hydrogels based on gelatin and poly(aspartic acid) derivatives, Lauren De Grave, Celeste Di Meo, Melanie Gerard, Annalisa La Gatta, Lieven Thorrez, Katrien V. Bernaerts, Chiara Schiraldi, Sandra Van Vlierberghe


  • Photo-crosslinkable Poly(aspartic acid) for Light-based additive Manufacturing: Chain-growth versus Step-growth crosslinking

    by Lauren De Grave, Celeste Di Meo, Coralie Gréant, Bo Van Durme, Melanie Gérard, Annalisa La Gatta, Chiara Schiraldi, Lieven Thorrez, Katrien V. Bernaerts, Sandra Van Vlierberghe


  • Open Access

    Human tissue-engineered skeletal muscle: a novel 3D in vitro model for drug disposition and toxicity after intramuscular injection

    by D. Gholobova, M. Gerard, L. Decroix, L. Desender, N. Callewaert, P. Annaert, L. Thorrez

    The development of laboratory-grown tissues, referred to as organoids, bio-artificial tissue or tissue-engineered constructs, is clearly expanding. We describe for the first time how engineered human muscles can be applied as a pre- or non-clinical model for intramuscular drug injection to further decrease and complement the use of in vivo animal studies. The human bio-artificial muscle (BAM) is formed in a seven day tissue engineering procedure during which human myoblasts fuse and differentiate to aligned myofibers in an extracellular matrix. The dimensions of the BAM constructs allow for injection and follow-up during several days after injection. A stereotactic setup allows controllable injection at multiple sites in the BAM. We injected several compounds; a dye, a hydrolysable compound, a reducible substrate and a wasp venom toxin. Afterwards, direct reflux, release and metabolism were assessed in the BAM constructs in comparison to 2D cell culture and isolated human muscle strips. Spectrophotometry and luminescence allowed to measure the release of the injected compounds and their metabolites over time. A release profile over 40 hours was observed in the BAM model in contrast to 2D cell culture, showing the capacity of the BAM model to function as a drug depot. We also determined compound toxicity on the BAMs by measuring creatine kinase release in the medium, which increased with increasing toxic insult. Taken together, we show that the BAM is an injectable human 3D cell culture model that can be used to measure release and metabolism of injected compounds in vitro.


  • Open Access

    Prolyl endopeptidase is involved in the degradation of neural cell adhesion moleculesin vitro

    by Külli Jaako, Alexander Waniek, Keiti Parik, Linda Klimaviciusa, Anu Aonurm-Helm, Aveli Noortoots, Kaili Anier, Roos Van Elzen, Melanie Gérard, Anne-Marie Lambeir, et al.

    Membrane-associated glycoprotein neural cell adhesion molecule (NCAM) and its polysialylated form (PSA-NCAM) play an important role in brain plasticity by regulating cell–cell interactions. Here, we demonstrate that the cytosolic serine protease prolyl endopeptidase (PREP) is able to regulate NCAM and PSA-NCAM. Using a SH-SY5Y neuroblastoma cell line with stable overexpression of PREP, we found a remarkable loss of PSA-NCAM, reduced levels of NCAM180 and NCAM140 protein species, and a significant increase in the NCAM immunoreactive band migrating at an apparent molecular weight of 120 kDa in PREP-overexpressing cells. Moreover, increased levels of NCAM fragments were found in the concentrated medium derived from PREP-overexpressing cells. PREP overexpression selectively induced an activation of matrix metalloproteinase-9 (MMP-9), which could be involved in the observed degradation of NCAM, as MMP-9 neutralization reduced the levels of NCAM fragments in cell culture medium. We propose that increased PREP levels promote epidermal growth factor receptor (EGFR) signaling, which in turn activates MMP-9. In conclusion, our findings provide evidence for newly-discovered roles for PREP in mechanisms regulating cellular plasticity through NCAM and PSA-NCAM.


  • Open Access

    High-content analysis of α-synuclein aggregation and cell death in a cellular model of Parkinson's disease

    by Francesca Macchi, Angélique Deleersnijder, Chris Van Den Haute, Sebastian Munck, Hans Pottel, Annelies Michiels, Zeger Debyser, Melanie Gerard, Veerle Baekelandt


  • Endothelial Network Formation Within Human Tissue-Engineered Skeletal Muscle

    by Dacha Gholobova, Lieselot Decroix, Vicky Van Muylder, Linda Desender, Melanie Gerard, Gilles Carpentier, Herman Vandenburgh, Lieven Thorrez

    The size of in vitro engineered skeletal muscle tissue is limited due to the lack of a vascular network in vitro. In this paper, we report tissue engineered skeletal muscle consisting of human aligned myofibers with interspersed endothelial networks. We extend our bio-artificial muscle (BAM) model by co-culturing human muscle progenitor cells with human umbilical vein endothelial cells (HUVECs) in a fibrin extracellular matrix. First, the optimal medium conditions for co-culturing myoblasts with HUVECs were determined in a fusion assay. Endothelial growth medium proved the best compromise for the coculture, without affecting myoblast fusion index. Second, both cell types were cocultured in a BAM maintained under tension to stimulate myofiber alignment. We then tested different total cell numbers containing 50% HUVECs and found that BAMs with a total cell number of 2.106 resulted in well aligned and densely packed myofibers while allowing for improved interspersed endothelial network formation. Third, we compared different myoblast-HUVEC ratios. Including higher numbers of myoblasts improved endothelial network formation at lower total cell density, however improvement of network characteristics reached a plateau when 1.106 or more myoblasts were present. Finally, addition of Matrigel to the fibrin ECM did not enhance overall myofiber and endothelial network formation. Therefore, in our BAM model, we suggest the use of a fibrin extracellular matrix containing 2.106 cells of which 50-70% are muscle cells. Optimizing these co-culture conditions allows for a physiologically more relevant muscle model and paves the way towards engineering of larger in vitro muscle constructs.


  • Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice

    by Marusela Oliveras-Salvá, Francesca Macchi, Valérie Coessens, Angélique Deleersnijder, Melanie Gérard, Anke Van der Perren, Chris Van Den Haute, Veerle Baekelandt


  • Open Access

    In Vitro Phosphorylation Does not Influence the Aggregation Kinetics of WT α-Synuclein in Contrast to Its Phosphorylation Mutants

    by Sarah Schreurs, Melanie Gerard, Rita Derua, Etienne Waelkens, Jean-Marc Taymans, Veerle Baekelandt, Yves Engelborghs

    The aggregation of alpha-synuclein (α-SYN) into fibrils is characteristic for several neurodegenerative diseases, including Parkinson’s disease (PD). Ninety percent of α-SYN deposited in Lewy Bodies, a pathological hallmark of PD, is phosphorylated on serine129. α-SYN can also be phosphorylated on tyrosine125, which is believed to regulate the membrane binding capacity and thus possibly its normal function. A better understanding of the effect of phosphorylation on the aggregation of α-SYN might shed light on its role in the pathogenesis of PD. In this study we compare the aggregation properties of WT α-SYN with the phospho-dead and phospho-mimic mutants S129A, S129D, Y125F and Y125E and in vitro phosphorylated α-SYN using turbidity, thioflavin T and circular dichroism measurements as well as transmission electron microscopy. We show that the mutants S129A and S129D behave similarly compared to wild type (WT) α-SYN, while the mutants Y125F and Y125E fibrillate significantly slower, although all mutants form fibrillar structures similar to the WT protein. In contrast, in vitro phosphorylation of α-SYN on either S129 or Y125 does not significantly affect the fibrillization kinetics. Moreover, FK506 binding proteins (FKBPs), enzymes with peptidyl-prolyl cis-trans isomerase activity, still accelerate the aggregation of phosphorylated α-SYN in vitro, as was shown previously for WT α-SYN. In conclusion, our results illustrate that phosphorylation mutants can display different aggregation properties compared to the more biologically relevant phosphorylated form of α-SYN.


  • Open Access

    Interaction of Transportin-SR2 with Ras-related Nuclear Protein (Ran) GTPase

    by Oliver Taltynov, Jonas Demeulemeester, Frauke Christ, Stéphanie De Houwer, Vicky G. Tsirkone, Melanie Gerard, Stephen D. Weeks, Sergei V. Strelkov, Zeger Debyser